ReviewChemical record (New York, N.Y.)2026
Unraveling the Physicochemical Landscape of Organoselenium Compounds in Nanocarrier Systems.
Review in Chemical record (New York, N.Y.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
In recent years, publications on organoselenium compounds have increased markedly, expanding their applications in therapeutic, nutraceutical, agricultural, and environmental fields. However, intrinsic properties such as high lipophilicity and chemical reactivity often limit their bioavailability and therapeutic performance. Advances in self-assembled nanostructures have enabled more efficient delivery, improving solubility and bioavailability while reducing toxicity. This review is the first to focus specifically on the physicochemical interactions governing the stability and performance of organoselenium-based nanostructures. We analyze recent formulations, emphasizing hydrophobic, van der Waals, electrostatic, and hydrogen bonding interactions that control nanocarrier behavior. Additionally, we discuss emerging strategies and future applications for the rational design of safer and more effective organoselenium delivery systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.